NCT04108221

Brief Summary

Interventional, randomised, prospective, multicentric study

Trial Health

33
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Trial recruitment is currently suspended
Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 16, 2019

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

September 26, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 30, 2019

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2022

Completed
Last Updated

April 7, 2022

Status Verified

June 1, 2021

Enrollment Period

2.5 years

First QC Date

September 26, 2019

Last Update Submit

March 29, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Evolution pain intensity scores, assessed by the numerical pain scale (EN), postoperative and need for systemic analgesics (intravenously or by mouth) during the 24 hours following the end of the procedure

    Evolution pain intensity scores, assessed by the numerical pain scale (EN 1 up to 10)

    24 hours

Secondary Outcomes (3)

  • Failure rate in the obese and / or malnourished patient subgroup

    24 hours

  • Time in minutes of each of the TAP Block techniques

    24 hours

  • Occurrence of trauma to the intra-abdominal organs caused by the injection needle

    24 hours

Study Arms (2)

Arm A : c-TAP Block performed by surgeon

EXPERIMENTAL

c-TAP Block Block performed by surgeon

Procedure: laparoscopy or laparotomy withTransversusAbdominis Plane Block

Arm B : us-TAP Block performed by anesthetist

ACTIVE COMPARATOR

us-TAP Block by anesthetist

Procedure: laparoscopy or laparotomy withTransversusAbdominis Plane Block

Interventions

The US-TAP is performed by the anesthetist under ultrasound control after the end of the procedure of laparoscopy or laparotomy. Under sterile conditions, the anesthetist identifies the oblique abdominal muscles externally, obliquely internally and transversely by ultrasound. A 20 ml needle of 0.5% ropivacaine is injected. The surgical TAP (c-TAP) block is performed by the surgeon at the end of the procedure of laparoscopy or laparotomy.The needle and the product used are identical to those of the us-TAP block. The positioning of the needle is in the plane of the fascia between the internal oblique muscle and the transverse muscle, identified by a significant loss of resistance.

Arm A : c-TAP Block performed by surgeonArm B : us-TAP Block performed by anesthetist

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient over 18 years old
  • Patient undergoing laparoscopic or laparotomic abdominal surgery at the investigator hospital.
  • Patient mastering the French language
  • Patient who received informed information about the study and signed a consent
  • Patient affiliated to a social security scheme.

You may not qualify if:

  • Patients with chronic pain
  • Patients with opioid dependence
  • Patients allergic to local anesthetic
  • Patient who has not signed the consent of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut Godinot

Reims, 51726, France

Location

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Laparoscopy

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

EndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Jean Christophe EYMARD, PI

    Institut GODINOT

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: two arms : arm A : c-TAP Block performed by surgeon arm B : us-TAP Block performed by anesthetist
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 26, 2019

First Posted

September 30, 2019

Study Start

September 16, 2019

Primary Completion

March 31, 2022

Study Completion

March 31, 2022

Last Updated

April 7, 2022

Record last verified: 2021-06

Locations